Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry  | Primary Offense Type | Year | Agency | Penalty Amount |
|---|---|---|---|---|---|---|
| AmerisourceBergen Corporation | AmerisourceBergen | wholesalers | False Claims Act and related | 2018 | DOJ_CIVIL | $625,000,000 |
| Cardinal Health Inc. | Cardinal Health | wholesalers | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $6,489,000,000 |
| AmerisourceBergen Corporation | AmerisourceBergen | wholesalers | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $6,510,000,000 |
| McKesson Corporation | McKesson | wholesalers | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $8,001,000,000 |
| Wisconsin Power and Light Company | Alliant Energy | utilities and power generation | air pollution violation | 2013 | EPA | $1,010,950,000 |
| Northern Indiana Public Service Co. | NiSource | utilities and power generation | environmental violation | 2011 | EPA | $613,000,000 |
| Westar Energy | Evergy Inc. | utilities and power generation | air pollution violation | 2010 | EPA | $509,000,000 |
| American Electric Power | American Electric Power | utilities and power generation | air pollution violation | 2007 | EPA | $4,675,000,000 |
| East Kentucky Power Cooperative | East Kentucky Power Cooperative | utilities and power generation | air pollution violation | 2007 | EPA | $650,750,000 |
| Ohio Edison Company | FirstEnergy | utilities and power generation | air pollution violation | 2005 | EPA | $1,133,500,000 |
| Dynegy Midwest Generation | Vistra Energy | utilities and power generation | air pollution violation | 2005 | EPA | $524,000,000 |
| Wisconsin Electric Power Company | WEC Energy Group | utilities and power generation | air pollution violation | 2003 | EPA | $623,200,000 |
| Virginia Electric Power Co. | Dominion Energy | utilities and power generation | air pollution violation | 2003 | EPA | $1,219,200,000 |
| Cinergy Corporation | Duke Energy | utilities and power generation | air pollution violation | 2000 | EPA | $1,430,000,000 |
| American Electric Power | American Electric Power | utilities and power generation | environmental violation | 2007 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,675,000,000 |
| Mirant Corporation | NRG Energy | utilities and power generation | price-fixing or anti-competitive practices | 2005 | CA-AG | $749,700,000 |
| Powerex | BC Hydro | utilities and power generation | price-fixing or anti-competitive practices | 2013 | CA-AG | $750,000,000 |
| Pacific Gas & Electric | PG&E Corp. | utilities and power generation | utility safety violation | 2019 | CA-MULTI | $1,000,000,000 |
| Duke Energy | Duke Energy | utilities and power generation | environmental violation | 2021 | NC-AG | $855,000,000 |
| Southern California Edison Co. | Edison International | utilities and power generation | utility safety violation | 2021 | CA-PUC | $550,000,000 |
| Pacific Gas & Electric Co. (PG&E) | PG&E Corp. | utilities and power generation | utility safety violation | 2020 | CA-PUC | $1,937,000,000 |
| Pacific Gas & Electric Co. (PG&E) | PG&E Corp. | utilities and power generation | utility safety violation | 2015 | CA-PUC | $1,600,000,000 |
| Pacific Gas & Electric | PG&E Corp. | utilities and power generation | utility safety violation | 2013 | private lawsuit-state | $565,000,000 |
| Pacific Gas & Electric Co. | PG&E Corp. | utilities and power generation | utility safety violation | 2020 | private lawsuit-federal | $13,500,000,000 |
| South Carolina Electric & Gas | Dominion Energy | utilities and power generation | consumer protection violation | 2019 | private lawsuit-state | $2,200,000,000 |
| U.S. Tobacco Co. | Altria | tobacco | price-fixing or anti-competitive practices | 2002 | private lawsuit-federal | $1,050,000,000 |
| British American Tobacco | British American Tobacco | tobacco | economic sanction violation | 2023 | DOJ_NATSEC | $629,000,000 |
| Zhongxing Telecommunications Equipment Corporation and ZTE Kangxun Telecommunications Ltd. | ZTE | telecommunications | export control violation | 2017 | BIS | $661,000,000 |
| Verizon Communications | Verizon Communications | telecommunications | telecommunications violation | 2018 | FCC | $614,300,000 |
| Zhongxing Telecommunications Equipment Corporation and ZTE Kangxun Telecommunications Ltd. | ZTE | telecommunications | export control violation | 2018 | BIS | $1,400,000,000 |
| Mobile TeleSystems PJSC | Mobile TeleSystems PJSC | telecommunications | Foreign Corrupt Practices Act | 2019 | DOJ_CRIMINAL | $750,000,000 |
| Ericsson | Ericsson | telecommunications | Foreign Corrupt Practices Act | 2019 | DOJ_CRIMINAL | $520,000,000 |
| Ericsson | Ericsson | telecommunications | Foreign Corrupt Practices Act | 2019 | SEC | $539,000,000 |
| Wal-Mart Stores | Walmart | retailing | wage and hour violation | 2008 | private lawsuit-federal/state | $640,000,000 |
| Walgreens | Walgreens Boots Alliance | retailing | off-label or unapproved promotion of medical products | 2022 | FL-AG | $680,000,000 |
| Walmart Stores | Walmart | retailing | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $3,100,000,000 |
| Walgreens | Walgreens Boots Alliance | retailing | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $5,700,000,000 |
| CVS | CVS Health | retailing | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $5,000,000,000 |
| Kroger | Kroger | retailing | off-label or unapproved promotion of medical products | 2023 | MULTI-AG | $1,370,000,000 |
| El Paso Corporation | Kinder Morgan | pipelines | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $1,450,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | FDA | $2,200,000,000 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $3,000,000,000 |
| Abbott Laboratories Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $1,500,000,000 |
| Merck, Sharp & Dohme | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $950,000,000 |
| SB Pharmco Puerto Rico Inc. | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2010 | FDA | $750,000,000 |
| Allergan Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $600,000,000 |
| AstraZeneca LP | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $520,000,000 |
| Amgen Inc. | Amgen | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $762,000,000 |
| Cephalon, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | FTC | $1,200,000,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2016 | DOJ_CIVIL | $784,600,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $2,300,000,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $1,415,000,000 |
| Merck & Company | Merck | pharmaceuticals | False Claims Act and related | 2008 | DOJ_CIVIL | $650,000,000 |
| Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | off-label or unapproved promotion of medical products | 2007 | DOJ_CIVIL | $515,000,000 |
| Serono, S.A. | Merck KGaA (EMD) | pharmaceuticals | off-label or unapproved promotion of medical products | 2005 | FDA | $704,000,000 |
| TAP Pharmaceutical Products Inc. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2001 | DOJ_CIVIL | $875,000,000 |
| Abbott Laboratories and CG Nutritionals | Abbott Laboratories | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $600,000,000 |
| Purdue Frederick Company Inc. | Purdue Pharma | pharmaceuticals | False Claims Act and related | 2007 | USAO | $600,000,000 |
| Amgen Inc. | Amgen | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $612,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $541,000,000 |
| Mallinckrodt | Mallinckrodt | pharmaceuticals | Controlled Substances Act violation | 2020 | MULTI-AG | $1,600,000,000 |
| Indivior Solutions | Indivior PLC | pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | $589,000,000 |
| Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $642,000,000 |
| Purdue Pharma LP | Purdue Pharma | pharmaceuticals | fraud | 2020 | DOJ_CIVIL | $8,344,000,000 |
| GlaxoSmithKline Holdings (Americas) | GlaxoSmithKline | pharmaceuticals | tax violations | 2006 | IRS | $3,400,000,000 |
| Merck & Co., Inc. | Merck | pharmaceuticals | tax violations | 2007 | IRS | $2,300,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $5,000,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | product safety violation | 2021 | private lawsuit-federal | $2,500,000,000 |
| Endo International PLC | Endo International | pharmaceuticals | drug or medical equipment safety violation | 2017 | private lawsuit-federal | $775,000,000 |
| Takeda Pharmaceutical Co. Ltd. | Takeda Pharmaceutical | pharmaceuticals | drug or medical equipment safety violation | 2015 | private lawsuit-federal | $2,400,000,000 |
| Boehringer Ingelheim International | Boehringer Ingelheim | pharmaceuticals | drug or medical equipment safety violation | 2014 | private lawsuit-federal | $650,000,000 |
| Endo International PLC | Endo International | pharmaceuticals | drug or medical equipment safety violation | 2014 | private lawsuit-federal | $830,000,000 |
| DePuy Orthopaedics, Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2013 | private lawsuit-federal | $2,475,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2010 | private lawsuit-federal | $770,000,000 |
| Pfizer | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2008 | private lawsuit-federal | $745,000,000 |
| Merck & Co. | Merck | pharmaceuticals | drug or medical equipment safety violation | 2007 | private lawsuit-federal | $4,850,000,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | drug or medical equipment safety violation | 2005 | private lawsuit-federal | $690,000,000 |
| Pfizer | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2004 | private lawsuit-federal | $750,000,000 |
| American Home Products | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2002 | private lawsuit-federal | $3,750,000,000 |
| Allergan | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $2,370,000,000 |
| Teva Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $4,250,000,000 |
| Biogen Inc. | Biogen | pharmaceuticals | False Claims Act and related | 2022 | DOJ_CIVIL | $900,000,000 |
| Forest Laboratories LLC | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $750,000,000 |
| Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $512,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | product safety violation | 2023 | private lawsuit-federal | $8,900,000,000 |
| Transocean | Transocean | oilfield services and supplies | oil spill | 2013 | EPA | $1,000,000,000 |
| Halliburton Energy Services Inc. | Halliburton | oilfield services and supplies | oil spill | 2017 | private lawsuit-federal | $1,028,000,000 |
| Anadarko Petroleum Corp. | Occidental Petroleum | oil and gas | environmental violation | 2015 | EPA | $5,150,000,000 |
| BP Exploration and Production Inc. | BP | oil and gas | oil spill | 2012 | DOJ | $4,000,000,000 |
| BP | BP | oil and gas | oil spill | 2015 | DOJ | $20,800,000,000 |
| BP | BP | oil and gas | investor protection violation | 2012 | SEC | $525,000,000 |
| ExxonMobil | Exxon Mobil | oil and gas | air pollution violation | 2005 | EPA | $589,400,000 |
| Valero | Valero Energy | oil and gas | air pollution violation | 2005 | EPA | $711,000,000 |
| ConocoPhillips | Phillips 66 | oil and gas | air pollution violation | 2005 | EPA | $539,500,000 |
| BP | BP | oil and gas | air pollution violation | 2001 | EPA | $660,000,000 |
| BP | BP | oil and gas | oil spill | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,900,000,000 |
| BP | BP | oil and gas | oil spill | 2015 | MS-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,500,000,000 |
| BP | BP | oil and gas | oil spill | 2012 | private lawsuit-federal | $7,800,000,000 |
| Exxon Corporation | Exxon Mobil | oil and gas | environmental violation | 2008 | private lawsuit-federal | $507,500,000 |
| Exxon Corporation | Exxon Mobil | oil and gas | price-fixing or anti-competitive practices | 2006 | private lawsuit-federal | $1,075,000,000 |
| BP EXPLORATION/MOEX/TRANSOCEAN DEEPWATER/TRITON/GULF OF MEXICO OIL SPILL/DEEPWATER HORIZON (NC) | BP | oil and gas | water pollution violation | 2016 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,377,250,000 |
